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ABSTRACT 
Comparison of Regular Ringer’s Solution and Glucose Ringer’s Solution on the 
Longevity of the Hirudo medicinalis’ Retzius Cell 
Nicole Arielle Peretti 
 
In 1882, Sydney Ringer, a professor of medicine at University College in London, 
experimented with the frog ventricle to better understand how each constituent of blood 
influences contraction.  The ultimate goal was to create an artificial circulating fluid to 
use for the perfusion of isolated organs, in this case, a frog heart. Today, Ringer’s 
solution is still used in research for physiological studies requiring the survival and 
maintenance of specimens outside of their host bodies.  One such example is the use of 
medicinal leech ganglia for electrophysiological measurements.  In this thesis, I am 
comparing two Ringer’s solutions, original versus added glucose, and their impact on the 
longevity of the ganglia.  By stimulating cells in the dissected ganglia submerged in 
Ringer’s solution with a micropipette, action potential responses can be recorded and 
used to compare longevity of the cells in each solution.  By providing the dissected 
ganglia with an additional source of fuel, I hypothesized that cells in the glucose-enriched 
Ringer’s solution would live longer, and thus provide action potentials longer, than cells 
in regular Ringer’s solution with a minimum increase in longevity of thirty minutes.   
Data analysis showed that glucose Ringer’s solution did not keep the cells alive longer 
than regular Ringer’s solution when the difference of means was set to 30 minutes.  
However, data did show a significant difference in the average longevity of the Retzius 
cell in glucose Ringer’s solution versus regular Ringer’s solution when the difference of 
means was set to zero.   
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CHAPTER 1:  INTRODUCTION 
It is often the case in research that an experiment will require the investigation of 
an organic organism outside of its natural environment.  With such requirements, the 
ability to artificially recreate various environments is a very important and crucial step in 
the progress of such research.  This concept is valid for a wide range of environments 
ranging from physical habitats to biological settings.  For example, behavioral studies 
using animals such as rats, mice, monkeys, or even humans, may require an experimental 
set-up that mimics what the natural environment would be for that subject.  This allows 
the results of an experiment to be attributed to a specific variable rather than the results 
being due to an abnormal testing environment. Even more critical, perhaps, is the 
recreation of an environment used for testing organisms that cannot survive outside their 
natural setting.  This is often the case when investigating microbiological organisms in 
vitro.  Regardless of environment type, artificial recreation of a subject’s surroundings is 
a very important aspect of research. 
 A perfect example of a microbial organism requiring an artificial 
environment is Legionella, the bacterium that causes Legionnaires’ Disease. For years 
following the first documented outbreak of this disease in 1965, thousands of deaths were 
documented per year [1].  It was clear something was causing this sickness, but what 
organism was responsible proved tragically difficult to discover.  It was not until January 
of 1977, over a decade later, that officials at the Center of Disease Control (CDC) 
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announced that they had found the pathogen causing Legionnaires’ Disease. After years 
of investigation, this pathogen was found to be a bacterium. Discovery of the bacterium 
required isolation in guinea pigs from autopsy specimens and propagation was performed 
in embryonated hens' eggs. [2] Nothing less than perfect combinations of several 
organisms were necessary for this bacterium to grow and be studied.  Now called 
Legionnaires' disease bacterium (LDB), the cultivation of this bacterium requires an 
artificial growth environment, that if not available, the bacterium does not grow. 
 In this thesis, artificial solutions are used to support packets of neuronal 
cells outside of their host bodies.  Similar to how a bacteria has requirements for growth, 
neuronal cells have their own set of requirements for communication and survival. 
Without an appropriate support solution, experiments on cells outside their host bodies 
would be impossible.  Motivation for this project was established by curiosity in an 
optimal solution that can increase cell longevity compared to the currently used solution.  
To perform this experiment, packets of cells, called ganglia, were dissected from 
medicinal leeches and submerged in a glucose-enriched Ringer’s solution and results 
compared to the already established Ringer's that does not contain glucose.  It was of 
interest to test if a glucose-enriched Ringer's solution would extend cell longevity when 
compared to original Ringer’s solution.   Thirty minutes was arbitrarily chosen as the 
desired amount of time that would allow for changes to an experimental paradigm.   
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CHAPTER 2:  RINGER’S SOLUTION 
There have been several solutions created for studying physiological states.  This 
section summarizes the research of Sydney Ringer, whose name and discoveries are still 
used in labs today.  Additionally, this section discusses some of the alterations to 
Ringer’s solution and how these solutions are used today.  
2.1  Sydney Ringer 
Development of artificial environments was investigated by the physiologist, 
Sydney Ringer.  Born in Norwich, England in 1835, Ringer came from a family of 
successful salesmen; Ringer’s interest, however, was in medicine.  In 1854, following a 
brief apprenticeship with a local medical practitioner, Ringer went to the University 
College in London.  In 1860, Ringer qualified for his Bachelors of Medicine (MB) and 
only three years later received his Doctorate of Medicine (MD) and became a member of 
the Royal College of Physicians where he became an assistant physician at the University 
College Hospital.  In 1887, Ringer became a professor of medicine, a position he retained 
until his retirement in 1900.  Ringer was an impressive worker and was inspired by many 
researchers working in anatomy and physiology.  During this time, when the standard 
research tools of today were just being developed, research ideas and opportunities were 
flourishing and the possibilities expanding.  One such influential invention was that of 
Carl Ludwig's, a Professor of Physiology at Marburg, Zurich, Vienna and Leipzig.   In 
1847, Ludwig designed the kymograph, or wave writer, which utilized a mercury filled 
manometer, a revolving drum and a stylus to simultaneously record changes in blood 
 4 
 
pressure and air pressure in a thoracic cavity.  With this device, pharmacologists were 
able to run experiments measuring changes in physiological function due to the 
administration of drugs. Additionally, Ludwig's second major contribution to the world of 
research was his method of supporting an isolated organ by perfusing it in an oxygenated 
nutrient solution.  Techniques such as these proved, years later, to be of great inspiration 
and use in Ringer's investigations including those on blood clotting, muscle contraction, 
and conduction of peripheral nerve impulses.  [3-5] 
It was in 1882 when Ringer began his studies on organic constituents of blood to 
see their influence on the contraction of the heart.  His ultimate goal was to create an 
artificial circulating fluid that would maintain a contracting heart.  Ringer used frogs as 
his animal model.  Contrary to the four-chamber mammalian heart, the frog heart 
contains three chambers: two atria and a single super-fused ventricle that contains two 
narrow chambers to prevent mixing of oxygenated and deoxygenated blood.  
Additionally, the frog heart contains no coronary vascular supply which allows for 
cleaner dissections.  Most importantly, however, is the availability of monocyte 
extracellular space inside the ventricular lumen that allows for easy and rapid ionic 
exchange with the extracellular fluid.  Furthermore, the frog heart has a slow contraction 
rate at room temperature, which is especially useful for more accurate recordings using a 
kymograph and when visual observation acts as the main source of evidence for research, 
as it did for most of Ringer's findings.  [6] 
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 Ringer first experimented with two circulating fluids: a saline solution and a 
blood mixture. His saline solution was "ordinary 0.75 percent solution of sodium 
chloride." The blood mixture contained one part dried bullock's blood to five parts saline 
solution.  Ringer used 100 cubic centimeters, or 100 milliliters, of either solution in each 
experiment. To circulate the fluid through the frog's heart and body, Ringer inserted a 
double cannulation tube through the atria and into the ventricle, tying the tube down as 
close as possible to the auriculo-ventricular groove.  Measurements were made using 
"Roy's tonometer," a device designed to measure transmission of volume using a closed 
vessel and a lever to report the movement of volume via an oil reservoir.  In this case, the 
changes recorded were that of ventricular volume.  [7] 
Ringer ran several experiments circulating the blood mixture and the saline 
solution through the frog heart.  His findings showed that circulating the saline solution 
caused a prolonged dilation, or enlargement, of the ventricle.  During dilation, blood 
enters the ventricle for expulsion to the rest of the body; when dilation is prolonged, 
blood is not getting delivered to the body as often and as naturally as it should. To further 
test the effects saline was having on the ventricle, Ringer tried a stronger saline solution, 
1.5 percent, and found the same results with an earlier occurrence than with the 0.75 
percent saline.  He also found that circulating the blood mixture after the saline solution 
would return the heart to a normal contraction, reversing the changes seen with saline 
solution.  Ringer questioned how the blood mixture, being mixed with saline solution and 
thus containing an excess of soda salts, did not also cause the prolonged ventricular 
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dilation.  Ringer found that after about sixty minutes of circulating the saline solution, 
contractions of the ventricle would become very weak and the dilations were still 
prolonged.  Within a short time of substituting the blood mixture for the saline, however, 
the contraction would grow stronger and the dilation would become quicker.  After forty 
minutes, the contractions were almost as good as at the beginning of the experiment.  It 
was clear that some constituent of blood in the blood mixture was eliminating the 
prolonged dilation cause by the saline solution alone.  [7] 
To investigate which constituent of blood was eliminating the prolonged dilation 
of the ventricle, Ringer introduced albumins and potassium chloride in the form of an egg 
white solution to the circulating saline solution.  The egg white solution, consisting of 
one part egg white to two parts water, was added after the saline solution expectedly 
initiated prolonged dilation.  It took only two minutes for the heart contractions to return 
to the state they were in when the heart was supplied with the blood mixture.  Ringer’s 
following experiments tested which constituent of the egg mixture removed the 
prolonged dilation.  By experimenting with both albumin and potassium chloride 
individually with the saline solution, Ringer found that even minute traces of potassium 
chloride in the saline solution would eradicate the prolongation of dilation seen with 
saline solution alone.  Experiments with albumin alone did not produce the same results.  
Ringer’s final experiments using a potassium chloride infused saline solution were able to 
keep the heart beating for over four hours with contractions consistent with the beginning 
of the experiment when the heart was supplied the blood mixture. Ringer was ultimately 
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able to conclude that a solution consisting of one cubic centimeter (one milliliter) of one 
percent potassium chloride solution in one hundred cubic centimeters (one hundred 
milliliters) of circulating saline made an excellent artificial circulating fluid for the heart.  
[7] 
It was not long after the publication of his findings, however, that Ringer 
discovered an error in his experiments that would greatly alter his conclusions.  The 
saline solution Ringer had used in his previous experiments had not been prepared with 
distilled water, but rather with pipe water supplied by the New River Water Company.  It 
was implied in Ringer's obituary several years later, that his lab technician had had a hard 
time keeping up with Ringer's demands for the lab. Under normal circumstances, the 
error of using tap water rather than distilled water could lead to many complications; 
however, in this case, it may have paved the path for Ringer's future findings.  He 
continued his research as follows:  
"...As this water contains minute traces of various inorganic substances, I at once 
tested  the action of saline solution made with distilled water and I found that I did not 
get the  effects described in the paper referred to.  It is obvious therefore that the effects I 
had  obtained are due to some of the inorganic constituents of the pipe water."  [8] 
Ringer's analysis of the tap water revealed that it contained 278.6 parts of solid 
per million.  This included "the presence of sodium, magnesium, potassium, carbonic and 
sulfuric acids, chloride and silicates".  [9]  Perhaps most significant, however, was the 
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presence of calcium at 38.9 parts per million.  Ringer’s subsequent paper, in 1883, 
investigated the influence of calcium and sodium salts added to saline solution on the 
action of the contraction of the ventricle.    
To continue and to correct his research, Ringer repeated his previous experiments 
with refined and new solutions.  The saline solution contained 0.75 percent sodium 
chloride and was now prepared with distilled water.  The calcium chloride solution was 
prepared with one part calcium chloride in 390 parts distilled water.  Lastly, the 
potassium chloride solution used was a one percent potassium chloride solution.  Using 
these solutions, Ringer found that circulating the calcium chloride solution produced the 
same changes in the ventricular beat that he had observed in his previous experiments: 
the ventricle contraction weakened and the diastolic dilation was prolonged. Ringer also 
found that with the addition of even minute traces of potassium salt, the effects of the 
calcium chloride solution on the ventricle were completely removed.  Therefore, although 
calcium salts are necessary for proper contraction of the heart, potassium salts are 
required in correct proportion to the calcium salts to antagonize the effects of calcium and 
allow for relaxation of the heart muscle.  [8]  The solution formulated through all his 
experiments is now known as Ringer’s Solution.  
Ringer’s solution was made to replace blood and provide a medium in which 
organisms can function and be studied outside of their natural environments.  Ringer was 
ahead of his time, and it was not until about twenty years later, with the knowledge of 
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diffusion and the disassociation of ions becoming a part of biological thinking, that 
Ringer’s solution really caught scientist’s attention.  [5] 
2.2  Modifications to Ringer’s Solution 
2.2.1  Frank S. Locke 
Since the time of Ringer’s studies, many scientists have made contributions and 
alterations to the established Ringer’s solution to fit their experimental needs.  Frank S. 
Locke, an English physiologist born in 1871, followed closely behind Ringer and in 1895 
studied the effects of different sources of tap water on the maintenance of physiological 
features; in his case, the contractility of the grass-frog Sartorius muscle.  [10]  Since tap 
water sources varied, Locke investigated these waters after their distillation and found 
that minute traces of various heavy metals were shown to have been dissolved in them.  
These metals rendered the water “poisonous” and when placed in glass storage 
containers, it would stain the glass with its poisons. It was found necessary to distill the 
water with the glass apparatus for some days to remove the poisonous residue from the 
glass.  From his experiments, Locke was able to conclude that certain crystalloids can be 
added to the water to prevent the fatal actions of traces of heavy metals, in his case, on 
the survival of tadpoles and tubifex fish.  [10] In another study, Locke found that the 
addition of dextrose to a suitable inorganic solution kept a frog heart working for over 24 
hours, much longer than Ringer’s experiments, which lasted two to five hours.  [11] 
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2.2.2 Maurice Vejux Tyrode 
Maurice Vejux Tyrode, an American physiologist and author of a 
pharmacological textbook summarizing the effects of several different drugs on 
physiological systems [12], altered the Ringer-Locke’s solution to contain magnesium, 
bicarbonate, and large proportions of phosphoric acid and is often gassed with carbon 
dioxide.  Like the Ringer-Locke solution, Tyrode’s solution also contains glucose.  [13]  
Today, Tyrode’s solution is used for several types of physiological experiments and cell 
culture applications.  
2.2.3  Alexis F. Hartmann 
 Intravenous saline solutions date back to Ringer’s time when Thomas Latta, who 
during the cholera epidemic in 1831-1832, pioneered its use for the treatment of cholera. 
[14-17]  Almost a century later, Alexis F. Hartmann and Dan C. Darrow, both American 
pediatricians, published a series of papers studying the chemical changes that occur in the 
body as a result of certain diseases and their suggested solution to remedy those toxic 
changes.  [18-20]  Their investigations on the composition of plasma found disturbances 
in acid-base balance, due primarily to the loss of bicarbonate from the plasma.  Through 
their studies, they concluded that proper administration of an alkali, such as sodium 
bicarbonate, along with correct concentrations of a salt solution, such as Ringer’s 
Solution, could provide rapid relief from acidosis.  [20] 
In 1929, Hartmann, in collaboration with Robert Elman, published further 
research on the treatment of acidosis.  In their paper, they present the several setbacks of 
 11 
 
bicarbonate as a remedy for acid-base disturbances and a solution to these setbacks.  [21]  
First off, for proper dosage measurements of bicarbonate, chemical examinations of 
blood were necessary, an important disadvantage when dealing with emergency 
situations.   Additionally, to eliminate the irritability of subcutaneous or intraperitoneal 
administration of a bicarbonate solution, it was necessary to sterilize the solution through 
a filtration process and adjust the pH to 7.4 by means of the addition of carbon dioxide, 
which, if not sealed, would once again become alkaline with the eventual loss of CO2. 
Even more, if administered intravenously, bicarbonate produced too rapid of a change in 
the reaction of body fluids and often resulted in a shift from acidosis to alkalosis. [22]  
Hartmann and Elman suggested a new solution containing an abundance of a fixed base, 
such as Sodium lactate, over the use of the fixed acid, bicarbonate.  [21]  The conversion 
of sodium lactate into sodium bicarbonate provided sufficient time for both the treatment 
of acidosis with less danger of alkalosis.  Furthermore, sodium lactate, both alone or 
combined with Ringer’s Solution is non-irritating and can be sterilized simply by boiling.  
[22]  Hartmann later used this lactated Ringer’s solution in a series of studies with Milton 
J. E. Senn [22-24] to study the metabolism of sodium lactate and combat metabolic 
acidosis in his young patients. Lactated Ringer’s solution is also known today as 
Hartmann’s solution. 
2.3 Ringer’s Solution Today 
Today, Ringer’s solution and its many alterations still play an active role in 
medicine and research.  Hartmanns’s solution and solutions like it are used in medicine 
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for fluid replacement for a variety of medical conditions. Ringer’s solution also continues 
to serve its purpose in research to study organisms outside of their host environments by 
providing the necessary electrolyte balance and recourses for survival of the organism.  In 
this project, Ringer’s solution was used to support ganglions outside of their host for the 
purpose of performing electrophysiological measurements.  The addition of glucose 
Ringer’s solution is not uncommon, however no formal study has been done to 
demonstrate the affect a glucose-enriched Ringer’s solution would have on the longevity 
of a leech cell.   
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CHAPTER 3:  THE NEURON 
To study survival of cells outside the normal environment that supports them, it is 
necessary to understand how the cell survives in its natural environment. In this thesis, 
neuronal cells were used which are excitable cells that receive, transmit, and analyze 
environmental information to coordinate an appropriate response.  The anatomy of the 
neuron is reviewed in this section and information is provided for understanding later 
sections that describe cell survival. 
3.1 The Nervous System 
The nervous system is a complex system comprised of excitable cells and tissues 
that provide three general functions: sensory feedback, motor control, and linking of the 
sensory and motor systems.  These functions are divided by the nervous system in two 
parts: The central nervous system (CNS) and the peripheral nervous system (PNS).  The 
CNS consists of the brain and the spinal cord and acts as a command station by 
processing sensory inputs and sending out response signals.  The PNS consists of the 
nerves that leave the CNS and travel to certain areas of the body and is responsible for 
receiving sensory input, transmitting it to the CNS, and then relaying CNS commands 
back to the body.  Proper functioning of these systems is crucial for survival of the 
organism.  Communication that enables the proper functioning of the nervous system as a 
whole is made possible by specialized, excitable cells called neurons.   
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Figure 3.1  Neuron Structures [21] 
3.2 Neuron Structure 
The neuron is the main signaling unit of the nervous system.  A typical neuron 
consists of four morphologically designed regions: the cell body, dendrites, the axon, and 
presynaptic terminals.  Figure 3.1 depicts these regions.  Each region has a distinct 
function in the generation of signals and in communicating those signals to other cells.  
3.2.1 The Cell Body 
The cell body, or the soma, is the brain of the neuron.  The soma is where cell 
genes are stored and proteins are synthesized. Like most other cells, the soma contains 
specialized organelles responsible for protein and energy production, along with other 
important activities. It is in the organelle called the mitochondria where the neuron’s 
supply of energy is created in the form of adenosine triphosphate (ATP).  Sprouting from 
the cell body are two different types of processes: multiple dendrites and one axon.   
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3.2.2 Dendrites 
Dendrites are responsible for receiving incoming signals from other cells.  
Neurons can have many dendrites, which branch many times, and are covered in 
dendritic spines where inputs from other cells are received.  The signal received is 
processed and in response can generate action potentials that propagated away from the 
cell body by a long process called the axon.   
3.2.3 The Axon 
The axon is the main conducting unit of the neuron capable of propagating signals 
along distances ranging from 0.1mm to as long as 2 or 3m. [25]  The axons of many 
neurons are wrapped in an insulating sheath of myelin composed of membranes of 
interstitial cells, Schwann cells outside the CNS and oligodendrocytes within the CNS.  
This insulating layer protects the axon and the propagating signal while increasing the 
speed of the signal.  Signals are regenerated as they travel down the axon in regular 
intervals gaps in the myelin sheath called nodes of Ranvier. Near its end, the axon splits 
into smaller branches, each of which end in a swollen structure called the axon terminal.  
3.2.4 Axon Terminals 
Axon terminals serve as the communication site to other neurons.  The cell 
transmitting the information is called the presynaptic cell, and thus, its axon terminals are 
referred to as presynaptic terminals.  Cells receiving the information are consequently 
called postsynaptic cells, and their terminals, postsynaptic terminals. The point at which 
communication occurs between the two cells is called a synapse.  
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3.2.5 Synapses 
The small gap that separates the two communicating cells is called the synaptic 
cleft.  In the synaptic cleft, chemical messengers are transferred from the presynaptic 
terminals to the postsynaptic terminals and thereby either stimulating or inhibiting the 
postsynaptic cell.   
3.3 Cellular Membrane 
The plasma membrane is the selectively permeable, outermost membrane of 
neurons and other tissue cells alike.  The membrane separates intracellular and 
extracellular environments and regulates the passage and exchange of molecules and 
ions.  Generally, 98% of the plasma membrane is composed of lipids, 75% of which are 
phospholipids.  The phospholipids form a bilayer characterized by hydrophilic head 
groups pointing outwards and hydrophobic tails pointing inwards.  See Figure 3.2.  This 
formation renders the membrane impermeable for most water-soluble molecules and 
open for very small and polar molecules to diffuse through.  [26] 
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Figure 3.2 Example of plasma membrane [27] 
The remaining 2% consists of diverse proteins embedded in the membrane that 
serve as channels for the passage of molecules from one side of the membrane to the 
other.  These channels are often selectively permeable to specific substances and open 
and close in response to different stimuli.  If molecules are to pass through the 
membrane, it will happen in one of two ways: simple diffusion or by means of a 
membrane protein.  Membrane proteins include ion channels and transporters. See Figure 
3.3. 
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Figure 3.3 Examples of ion transporters and ion channels [28] 
3.3.1 Ion Channels  
Ion channels allow rapid membrane passage of an ion by means of facilitated 
diffusion.  They are selectively permeable and alternate between an open and closed 
state.  Some ion channels can be “gated” and require a stimuli to open.  Such stimuli 
include changes in membrane potential or the binding of a neurotransmitter or ligand.  
Ion channels that are sensitive to changes in membrane potential are called voltage-gated 
ions and they are fundamental for neuronal excitability.   
3.3.2 Transporters 
Transporters, or carriers, actively bind molecules to transport them across the 
membrane.   Transporters can move molecules in either direction across the cell 
membrane, in what is called passive or active transport. Passive transport moves 
molecules with their concentration or electrochemical gradient; Active transport is the 
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movement of molecules against these gradients. The gradients are created due to 
differences in concentrations and electrical charges of ions inside and outside the cell.  
While passive transporters can “passively” transport molecules across the membrane, 
active transport requires energy derived by the hydrolysis of adenosine triphosphate 
(ATP) to push molecules against their “passive” or natural flow direction.  The cellular 
membrane is what keeps intracellular and extracellular fluid compositions separated 
while active transporters maintain the intracellular and extracellular ionic concentrations.  
These differences in ionic concentrations inside and outside the cell generate an electrical 
field across the membrane called the membrane potential. 
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CHAPTER 4:  MEMBRANE POTENTIAL 
Water is the most abundant molecule in the body, making up about 99 percent of 
all the molecules of the body.  0.25 percent can be attributed to proteins and nucleic 
acids.  The final 0.75 percent, then, consists of simple inorganic substances, mainly 
sodium, potassium, and chloride ions.  [27]  It is a combination of water and these simple 
organic substances that make up the intracellular (ICF) and extracellular fluids (ECF) that 
keep nerve cells alive and capable of transmitting information from one cell to another.  
This section will detail the cellular membrane environment and resting state 
characteristics that set the stage for cellular excitability. 
4.1 Intracellular and Extracellular Environments 
As mentioned previously, fluids inside and outside the cell are different in 
composition and are kept separate by the cell’s outermost membrane, the plasma 
membrane.  Table 4-1 shows the simplified compositions of ICF and ECF, and whether 
or not the constituents can cross the plasma membrane.  A
-
 comprises all intracellular 
anions (negatively charged ions) which includes protein molecules, amino acids, and 
other inorganic ions.   
Intracellular concentrations of cations are dominated by potassium, and contain 
much less sodium.  Conversely, extracellular concentrations are dominated primarily by 
sodium, and much less potassium.  Also important is whether or not a substance can cross 
the plasma membrane.  The plasma membrane is permeable to potassium, chloride, and 
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water, and less permeable to sodium.  This difference in intracellular and extracellular 
concentrations plays an important role in the resting state of the cell.   
Table 4-1 Intracellular and extracellular ionic compositions for a typical mammalian cell [27] 
 Internal 
concentration 
[mM] 
External 
concentration 
[mM] 
Can it cross the 
plasma 
membrane? 
K
+
 125 5 Y 
Na
+
 12 120 N* 
Cl
-
 5 125 Y 
A
-
 108 0 N 
H2O 55,000 55,000 Y 
* Section 4.2 will show how this “no” is not exactly accurate 
 
4.2 Resting Membrane Potential 
4.2.1 Electrochemical Gradient 
The electrochemical gradients are the gradients created due to differences in 
intracellular and extracellular ion concentrations and electric charges.  Ion channels and 
transporters work in conjunction and maintain both the electric and chemical potentials.  
Chemical gradients are established by differences in concentrations of specific ions 
across the membrane. Ion channels then facilitate ionic diffusion of permeable ions in the 
direction of their chemical gradient.  Electric gradients are established by the electrostatic 
forces ions exert on one another.  Ions with like charges will repulse one another while 
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ions with opposite charges will attract one another.  Transporters allow movement of ions 
against these gradients. [26, 28] 
Equilibrium potentials exist for each permeable ion.  The electrochemical gradient 
is at an exact balance between the two opposing forces.  At cellular rest, however, 
interacting electrochemical gradients of sodium and potassium ions and ion membrane 
permeability generate what is called the resting membrane potential.  At rest, 
electrochemical gradients are not equal to zero; rather, movement of ions through open 
channels and down their electrochemical gradient still occurs and, in combination, create 
the resting membrane potential. [27] 
4.2.2 Sodium-Potassium Pump 
The sodium-potassium pump (Na
+
/K
+
 ATPase) is the active transporter essential 
in maintaining the membrane potential; it is an energy-dependent transporter that uses 
energy derived from the hydrolysis of ATP to actively transport sodium and potassium 
ions against their electrochemical gradient.  As seen in Table 4-1, internal concentrations 
of ICF are dominated by potassium, while external concentrations are dominated by 
sodium.  The sodium-potassium pump works by binding three sodium ions and one ATP 
at the intracellular face of the membrane and, using the cleaved energy of ATP 
hydrolysis, releases the sodium outside of the cell.  The protein must then bind two 
potassium ions on the outer surface of the cell membrane to return to the configuration in 
which it can again bind sodium and ATP.  [26, 27]   
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Sodium-potassium pumps are necessary in restoring intracellular and extracellular 
concentrations of sodium and potassium that are lost to leak channels.  Leak channels are 
present in nerve cells and passively allow sodium or potassium to flow down their 
concentration gradients.  The cell membrane has many potassium leak channels which 
allow potassium to leave the cell.  The sodium-potassium pump adjusts for this “leak” of 
potassium out of the cell and preserves a constant membrane potential. [29] 
4.2.3 Ion Permeability and Regulation 
Membrane potential is most influenced by sodium and potassium concentrations 
and permeabilities.  At rest, the membrane potential reaches a point at which sodium 
influx is balanced by potassium efflux. Most cells experience a much higher permeability 
to potassium than sodium, and thus the balance rests closer to the equilibrium potential 
for potassium.  To keep the resting membrane potential at a steady state, there is a 
constant exchange of intracellular potassium for sodium which is regulated by the 
sodium-potassium pump.  [27, 28] 
4.3 Theory 
4.3.1 Nernst Equation 
The electrical potential generated across the membrane at electrochemical 
equilibrium, the equilibrium potential, can be calculated using the Nernst equation: 
𝐸𝑥 =  
𝑅𝑇
𝑧𝐹
ln
[𝑋]2
[𝑋]1
 ………………………………..Equation 1 
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The Nernst equation calculates the equilibrium potential for one ion at a time and 
only to ions that can cross the barrier. [27]  At equilibrium, net force driving an ion in 
crossing the barrier is zero; the Nernst equation relates the electrical potential and 
distribution of charged ions across the permeable membrane.  [29]  Below is a table 
showing ionic concentrations and associated Nernst potentials for a squid neuron and a 
mammalian neuron. 
 
Table 4-2 Ion Concentrations and Nernst Potentials [27, 28] 
Ion Internal 
[mM] 
External [mM] Nernst Potential 
[mV] 
Squid Neuron    
K
+
 400 20 -75 
Na
+
 50 440 +55 
Cl
-
 40 560 -66 
Mammalian 
Neuron 
   
K
+
 125 5 -82 
Na
+
 12 120 +59 
Cl
-
 5 125 -82 
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4.3.2 Goldmann Equation 
The Goldmann equation relates ion concentrations and permeabilities to calculate 
the membrane potential. This equation is similar to Nernst equation except that it takes 
into consideration the ions of sodium, potassium, and chloride: 
𝐸𝑚 =  
𝑅𝑇
𝐹
ln (
𝑃𝐾[𝐾
+]𝑜+ 𝑃𝑁𝑎[𝑁𝑎
+]𝑜+ 𝑃𝐶𝑙[𝐶𝑙
−]𝑖
𝑃𝐾[𝐾+]𝑖+ 𝑃𝑁𝑎[𝑁𝑎
+]𝑖+ 𝑃𝐶𝑙[𝐶𝑙
−]𝑜
) …………………..Equation 2 
In most nerve cells, the effect of chloride on the resting membrane potential is 
insignificant and can be dropped from the Goldmann equation: 
𝐸𝑚 =  
𝑅𝑇
𝐹
ln (
𝑃𝐾[𝐾
+]𝑜+ 𝑃𝑁𝑎[𝑁𝑎
+]𝑜
𝑃𝐾[𝐾+]𝑖+ 𝑃𝑁𝑎[𝑁𝑎
+]𝑖
)………………….Equation 3 
Resting membrane potentials vary among different cells. For a mammal neuron, 
the Goldmann equation yields 𝐸𝑚 = -71 mV.   It is expected that the resting potential 
would lie closer to 𝐸𝐾 (-82mV) than to 𝐸𝑁𝑎 (+59mV) due to the higher permeability to 
potassium.  The Nernst and Goldmann equations are able provide valuable information 
about cell membrane permeability and intracellular and extracellular ionic concentration. 
[27, 28]  
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CHAPTER 5:  THE ACTION POTENTIAL 
Neurons send and receive signals to other cells by means of electrical or chemical 
steps that are produced by modulating the membrane potential.  The following section 
describes how these signals, called action potentials, are generated, propagate, and are 
passed from one cell to the next.  
5.1 Action Potential Overview 
An action potential is the signal that carries messages over long (and short) 
distances in the nervous system.  These messages start at the origin of the axon, called the 
axon hillock, and are quickly propagated along the axon by means of all-or-none 
impulses.  Action potentials are initiated by a transient, dramatic increase in sodium 
permeability causing a rise in the membrane potential and are normally triggered by some 
external stimulus.   
5.2 Permeability during an Action Potential 
5.2.1 Voltage-Dependent Sodium Channels 
At cellular rest, membrane sodium channels are mostly closed and the resting 
potential lies closer to that of the potassium equilibrium value.  When the membrane is 
depolarized due to external stimuli, voltage-dependent sodium channels are triggered to 
open, allowing sodium ions to carry positive charge into the cell, further depolarizing the 
membrane.  Voltage-gated sodium channels and membrane depolarization form a 
positive feedback cycle causing a depolarization of the membrane. 
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Figure 5.1 Cycle that leads to the depolarization of the plasma membrane [27] 
This cycle is the start of an action potential and tends to continue until membrane 
potential reaches near to the value of the sodium equilibrium potential.  This phenomenon 
also explains the all-or-none behavior of the action potential.  Once triggered, the process 
tends to run to completion. [27] 
 For this cycle to start, however, membrane potential must reach a threshold.  For 
moderate depolarization, potassium efflux may be larger than the influx of sodium and 
prevent the positive feedback cycle essential to the action potential.  The membrane 
potential threshold reached must be at the point where the influx of sodium surpasses the 
efflux of potassium. This threshold value can vary for different neurons. 
5.2.2 Repolarization 
There are two factors that will restore the resting membrane potential of a cell: 1) 
the depolarization-induced increase in sodium permeability is transient, and 2) there is a 
delayed, voltage-dependent increase in potassium permeability.  [27] 
The transient nature of the voltage-gated sodium channels is seen in Figure 5.2.  
The sodium channel contains two gates, both of which respond to depolarization but with 
different speeds and in opposite directions.  Image a) shows the m gate closed when the 
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cell membrane is at resting value.  At the same time, the h gate remains open.  Image b) 
depicts how the m gate opens in response to membrane depolarization and sodium is able 
to enter the cell.  Meanwhile, the h gate begins to close, but at a slow rate. Image c) 
shows the h gate closed; this state is called sodium channel inactivation. 
a) b)  
c)  
Figure 5.2 Schematic showing the behavior of a single voltage-sensitive sodium channel [27] 
Voltage-sensitive potassium channels consist of one gate called the n gate.  The n 
gate is closed at membrane resting potential and opens slowly with depolarization.   This 
allows for the efflux of potassium while the resting membrane potential returns to normal 
resting value.  See Figure 5.3.   
At rest 
Em = -75mV 
m gate closed 
h gate open 
Immediately after  
depolarization 
Em = -50mV 
m gate open 
h gate open (slowly closing) 
5ms after  
depolarization 
Em = -50mV 
m gate open 
h gate closed 
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Figure 5.3 Schematic showing the behavior of a single voltage-sensitive potassium channel [27] 
5.3 Phases of an Action Potential 
 
Figure 5.4 Schematic of phases of an action potential [30] 
Immediately after  
depolarization 
n gate closed 
5ms after 
depolarization 
n gate open 
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5.3.1 Resting Phase 
 The resting phase of an action potential is when the cell membrane is at a steady 
state and capable of generating an action potential.  For a typical mammalian cell, this is 
true at about -71mV, somewhere between the Nernst potential for potassium (-82mV) 
and the Nernst potential for sodium (+59mV), but closer to that of potassium.  These 
values vary for different cell types.  During the resting phase, the m and n gates are 
closed and the h gate is open.  The resting membrane potential is kept constant by means 
of the sodium-potassium pump. 
5.3.2 Depolarization Phase 
The depolarization phase occurs when a stimulus of sufficient magnitude 
increases the membrane potential above its threshold value.   When threshold is reached, 
m gates open, sodium rushes into the cell and the membrane potential rises to a value 
near that of the sodium equilibrium.  During this phase, the h gate slowly closes and the n 
gate slowly opens in preparation for repolarization of the membrane.   
5.3.3 Repolarization Phase  
The repolarization phase begins once the membrane potential has reached its 
maximum.  The slow-acting sodium channel h gate is closed and the potassium channel n 
gate is now fully open where potassium ions flow out of the cell until the membrane, 
once again, reaches resting potential.   
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5.3.4 Hyperpolarization Phase 
After repolarization, sodium h gates reopen allowing sodium levels to normalize 
while potassium n gates close slowly, allowing potassium to leave the cell.  The extra 
efflux of potassium ions that occurs while the n gates close decreases the membrane 
potential to below that of the resting value.  This is called the hyperpolarization phase, or 
undershoot phase, of the action potential.   
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CHAPTER 6:  CELLULAR RESPIRATION AND CELL SURVIVAL 
Cellular respiration is the process a cell takes to break down fuel and generate 
energy in the form of ATP.  ATP is used for many cell functions including transport 
work, mechanical work, and chemical work.  Mechanical work includes the supply of 
energy for muscle contraction.  Chemical work includes the supply of energy needed to 
synthesize the many types of macromolecules cells need to exist. Transport work, as we 
are now familiar with, includes the supply of energy needed to move substrates across the 
cell membrane. [31]  Perhaps most notable for this thesis is the need of ATP for the 
function of the sodium potassium pump.  The sodium potassium pump maintains the 
resting membrane potential and is critical for survival and communication of nerve cells.  
This section will give a brief description on how eukaryotic cells synthesize ATP as well 
as an explanation of how this process was considered when developing ways to increase 
survival of cells in an in vitro condition.  
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Figure 6.1 Overview of cellular respiration and ATP production count [31] 
6.1 Synthesis of ATP 
6.1.1 Glycolysis 
Glycolysis actually means “sugar splitting.”  This process occurs in the cytosol of 
the cell and is the beginning of the breakdown of glucose. During this process, glucose, a 
six-carbon sugar, is converted into two molecules of the compound pyruvate.  Although 
glycolysis requires energy to breakdown glucose, the net yield produces two ATP.   This 
process releases less than a quarter of the chemical energy in glucose that can be used by 
cells.  If molecular oxygen is present, the pyruvate molecules produced during glycolysis 
can enter the mitochondrion where cellular respiration is completed. [31] 
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6.1.2 Krebs cycle 
When pyruvate molecules enter the mitochondrion, they are first converted to a 
compound called acetyl coenzyme A, or acetyl CoA.  Acetyl CoA then enters what is 
called the citric acid cycle, or Krebs cycle.  The Krebs cycle consists of several steps that 
yield one ATP per cycle.  This portion of cellular respiration produces two ATP, one for 
each Acetyl CoA that goes through the Krebs cycle. [31]  
In addition to the ATP produced from glycolysis and the Krebs cycle, these 
processes also produce free hydrogen ions (H
+
).   NAD
+
 (nicotinamide adenine 
dinucleotide) and FAD (flavin adenine dinucleotide), both well-suited electron carriers, 
form NADH and FAHD2, respectively, and carry H 
+
 ions to the third stage of cellular 
respiration, the electron transport chain.  [31] 
6.1.3 Electron Transport Chain 
So far, only four ATP molecules have been produced via glycolysis and the Krebs 
cycle, two from each.  Most of the energy extracted from glucose is actually stored in the 
NADH and FADH2 molecules. The H
+ 
ions being carried by these molecules are 
transferred to inner mitochondrion membrane proteins called cytochromes which pump 
the H
+ 
ions across the membrane into an intermembrane space.  This creates a gradient of 
H
+ 
ions across the membrane referenced as the proton-motive force.  This gradient then 
drives the H
+ 
ions down their gradient through membrane protein channels called ATP 
synthase, the enzyme that actually makes ATP from ADP.  This process of energy stored 
in the form of an H
+ 
ion gradient across a membrane to drive ATP synthase is called 
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chemiosmosis.  The ATP synthase, the only channel for which H
+ 
ions can move down 
their concentration gradient, functions like an ion pump, but, in reverse, producing ATP 
from ADP and Pi.  [31] 
The electron transport chain can produce a maximum of 28 ATP form one 
glucose molecule.  Adding ATP produced from glycolysis and the Krebs cycle, total ATP 
yield for one glucose molecule is 32 ATP.  [31] 
6.2 Surviving Cells in vitro 
In the body, cells have access to the molecules used to generate energy, such as 
glucose, through the food consumed by the host.   When cells are studied in vitro, they 
must depend solely on the artificial environment in order to stay alive.  A solution to 
support neurons in vitro must, at minimum, contain the ions that exist in the intracellular 
and extracellular fluids of its natural environment (Na
+
, K
+
, Cl
-
, etc.).  It is also crucial to 
mimic the pH of the cell’s natural environment.  Additional ingredients to the artificial 
environment can then be added, or substituted, to cater to individual experiments.  
Ringer’s solution is a known solution for supporting cells outside their host body and a 
common starting point for artificial cellular environments.  This solution contains the 
appropriate concentrations of ions that are isosmotic to the host cell and mimic the 
natural extracellular environment.   
In this experiment, it was attempted to extend the longevity of action potential 
recruitment, and essentially survival, of a neuronal cell separated from its natural fuel 
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resources.  Although still inside the ganglion, these neurons are now dependent on the 
resources provided by an external fluid versus that provided by the host body, in this 
case, a leech.  Neurons have very limited glucose storage and a shortage of glucose 
would be detrimental to the cell. Under normal metabolic conditions, cytoplasmic levels 
of ATP are 10mmol/L, which is essential for virtually all neuronal functions, 60% of 
which is used for the sodium potassium pump to maintain the resting membrane 
potential. [32]   Because glucose is necessary for neurons to produce adequate amounts of 
ATP for survival, it was of interest to see if the addition of glucose to Ringer’s solution 
would extend the life of neurons compared to the normal Ringer’s solution.   
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CHAPTER 7:  RINGER’S SOLUTION PREPARATIONS 
There have been several alterations to Ringers solution to cater to individual 
experiments.  For the purpose of this experiment, two Ringer’s solutions were prepared, 
one with glucose and one without.  This section goes over the ingredients and 
preparations of both solutions. 
7.1 Regular Ringer’s Solution 
Regular Ringer’s solution contains the necessary ingredients to keep a cell alive 
for a certain amount of time when removed from its natural environment. The table 
below details the ingredients and concentrations of regular Ringer’s solution as well as 
the concentrations of the stock solutions available in the Cal Poly Leech 
Electrophysiology lab.   
Table 7-1  Stock solutions available at Cal Poly Electrophysiology Lab and Ringer’s Solution Recipe  
 Stock Solutions (M) Regular Ringer’s (M) 
NaCl 3 .115 
CaCl2 1 .0018 
KCl 1 .004 
Tris Maleate 0.2 .01 
 
To reach the desired regular Ringer’s solution concentrations, it was necessary to 
calculate how much of each stock ingredient would be required, in this case, for a one 
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liter solution.  The table below shows the volumes required for the dilution of each 
ingredient to make one liter of Ringer’s solution with the correct ingredient 
concentrations.  Refer to appendix A for detailed calculations.  
Table 7-2 Volumes of ingredients needed from stock to make Ringer’s solution 
 NaCl (mL) CaCl2 (mL) KCl (mL) Tris Maleate (mL) 
Regular Ringer’s 38.33 1.8 4 50 
 
All Ringers’ solutions were prepared with distilled water. When preparing the 
solution, a small amount of distilled water was separated into a measuring cup and used 
to mix in other ingredients.  After ingredients were pipetted in, the solution was topped 
off to about 900 ml.   pH measurements were then taken and the solutions were titrated 
using either hydrochloric acid or sodium hydroxide, as needed, until the pH was 7.4.  
When the pH was stable at 7.4, the solution was topped off to one liter with distilled 
water and transferred over to a one liter, sealable glass container labeled with the type of 
solution (regular or glucose), the date, and the pH.  Ringer’s solutions used for 
dissections were kept refrigerated at the same temperature as the leeches.   
7.2 Glucose Ringer’s Solution 
Glucose Ringer’s solution contains the same ingredients as the regular Ringer’s 
solution described in the previous section with the addition of glucose.  Other 
experiments have used glucose in their Ringer’s solutions ranging from 10-13 mM 
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concentrations.  [33-35]  For this experiment, a 13 mM concentration was chosen for the 
glucose Ringer’s solution.   
To make a 13 mM concentration glucose Ringer’s solution, it was necessary to 
calculate how much glucose would be required to make, in this case, a one liter solution.  
Using the molecular weight of glucose (180.16 grams per mole), it was calculated that 
2.34 grams of glucose in a one liter solution would make a solution with a 13 mM 
concentration of glucose.  Refer to appendix A for detailed calculations.   
Glucose Ringer’s solution was prepared using a liter of regular Ringer’s solution 
made with distilled water.  2.34 grams of glucose was mixed into about half a liter of 
regular Ringer’s solution.  Once dissolved, regular Ringer’s solution was added to about 
900mL and the solution was titrated using either hydrochloric acid or sodium hydroxide, 
as needed, until the pH was 7.4.  When the pH stabilized at 7.4, the solution was topped 
off to one liter with the remaining Ringer’s solution. Glucose Ringer’s solution was 
stored in a one liter, sealable glass container labeled with the type of solution (regular or 
glucose), the date, and the pH.  Glucose Ringer’s solution used for dissections was kept 
refrigerated at the same temperature as the leeches.   
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CHAPTER 8:  HIRUDO MEDICINALIS AND DISSECTION PROTOCOL 
Neuronal electrophysiology research has greatly benefited from the study of 
invertebrate nervous systems.  The simplicity of the nervous system in such animals has 
facilitated research in many areas of the nervous system. One such animal fundamental to 
this research is the medicinal leech, more specifically, Hirudo medicinalis.  This section 
covers the anatomy and nervous system of the leech, necessary care instructions, and 
finally, a detailed protocol for the extraction of a mid-body ganglion of the Hiudo 
mediciniali.  For this thesis, fifteen experiments were performed. 
8.1 Hirudo Medicinalis 
8.1.1 Leech Anatomy 
Leeches are segmented worms, or annelids, with a fixed number of segments (32). 
These thirty-two segments are further divided into three sections based on location and 
function.  The “head” consists of the four most anterior segments which are fused 
together to form the eyes and the mouth.  The “tail” is also fused, consisting of the seven 
most posterior segments to form the large caudal sucker. Between the “head” and the 
“tail” are twenty one unfused, mid-body segments (M1-M21).  Directly under the skin, 
the leech has three layers of muscle fibers. The outer layer is composed of circular 
muscle fibers, the inner layer of longitudinal muscle fibers, and the intermediate layer of 
two sheets of crossed oblique muscle fibers.  Two other sets of muscle fibers may be 
found along the body of the leech, altogether permitting multidirectional contractions. 
[36] 
 41 
 
 
A.  
B.  
Figure 8.1 Anatomy of medicinal leech. A. Diagram of external body with outline of CNS 
positioning B. Cut-away diagram of mid-boy segment showing muscles and major organs.  [36] 
8.1.2 Leech Nervous System 
The leech nervous system reflects the segmental layout described above. Along 
the length of the leech is a ventral nerve cord with thirty-two segmentally associated 
ganglia. The four most anterior are fused together to form the anterior brain, and the 
seven most posterior are fused together to form the posterior brain.  An unpaired, median 
connective called “Faivre’s nerve” links the segmental ganglia to one another, while two 
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paired connective roots branch out laterally from the ganglia and innervate the body wall 
musculature to anchor them.  These connectives contain both interganglionic axons and 
longitudinal muscle fibers.  [36] 
Each segmental ganglion contains about 200 pairs of neurons and a few unpaired 
neurons.  Different neurons are responsible for a diverse set of functions depending on 
the nerve type and location of the ganglia.  Neurons from mid-body region ganglia have 
been most successfully mapped and categorized based on nerve function.  The most 
effectively identified cell types include: the Retzius cell, the T cell, the P cell, and the N 
cell.  [36] 
A. B.  
Figure 8.2 Mid-body ganglion anatomy. A. Ventral aspect. B. Dorsal aspect.  [36] 
 The Retzius cells, or R cells, are the two large cells seen clearly in the center on 
the ventral aspect of the ganglia. .  The R cells are effector cells that contain serotonin 
and are involved in mucus release, swimming, and relaxation of the longitudinal muscles. 
The T, P, and N cells are mechanosensory cells.  The T cells are sensitive to touch, the P 
cells to pressure, and the N cells to noxious stimuli.  [36] 
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8.1.3 Cell Selection 
Cell selection for this set of experiments was determined based on experimental 
reproducibility, cell identification, and cell accessibility to recording equipment.  The 
Retzius cell is far superior with respect to these qualifications due to its size and location 
in the ganglia.  Choosing the Retzius cell helped reduce variability in the experimental 
procedure.  
8.2 Leech Care 
Leeches for this thesis were purchased from LEECHES U.S.A. LTD. and placed 
directly into a refrigerator for about twenty four hours, or until leeches were sedated by 
the cool temperature.  Leeches were then transferred to a container filled with a saltwater 
solution (2grams LE2004 HIRUDO® salt in one gallon distilled water).  The container 
has two sections, one bucket with holes fitting inside another holding the saltwater. The 
container is filled about half way with the saltwater solution and the leeches are 
transferred from their arrival packaging to the container using large tongs. Both sections 
of the container have a top that must be taped down to prevent the leeches from leaving 
the container.  The container is placed in the refrigerator to keep leeches sedated until 
they are used for experiments. Saltwater is replaced every one to two weeks or earlier if 
saltwater looks dirty. To replace saltwater, it is best to have a second container to transfer 
leeches into and then fill up with fresh saltwater.  The dirty water is dumped down a drain 
and both sections of the container are rinsed with distilled water and left to dry until the 
next saltwater replacement.   
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8.3 Ganglia Extraction  
8.3.1 Ganglia Extraction Tools 
Fifteen experiments were performed for this thesis.  The following lists the tools 
used for a mid-body ganglion extraction from the leech in preparation for 
electrophysiological recordings: 
Dissection Table 
Glucose Ringer’s Solution (pH 7.4) 
Large Tongs 
Leeches 
Leech Mobile Home 
Light Source 
Micro Pins (~ 5mm)  
Microscope  
Paper Towels 
Push Pins 
Refrigerator 
Regular Ringer’s Solution (pH 7.4) 
Surgical Scalpel 
Surgical Scissors  
Surgical Tweezers (w/ curved tip) 
Surgical Tweezers (w/ fine point) 
Silicon-Filled Petri Dish (large) 
Silicon-Filled Petri Dishes (small) x2 
8.3.2 Ganglia Extraction Procedure 
1. Leech Preparation 
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a. Using large tongs, carefully grab one leech and place on large silicon-
filled petri dish. Use tongs to hold leech down and use a pushpin to pin 
down one side of leech towards the edge of petri dish.  Use a second 
pushpin to pin the other side of the leech and stretch to the opposite side of 
the petri dish. Cover the leech in Ringer’s solution.   
b. Use tweezers to pinch a small section of skin at one end of the leech, 
approximately 10mm from the end, and cut incision using scissors. Now 
place one blade of the scissors in the incision and cut along the center of 
the leech, pulling up on the skin as to not cut too deep, for about 20mm. 
Pass scissors along incision a couple times to make sure top layer of skin 
is fully cut.   
c. Use four more pushpins to stretch out both sides of the incision outward 
from the centerline of the leech, making of taut rectangle with one pushpin 
on each corner as close to the edge of the leech’s skin as possible. Several 
ganglia should now be exposed.  Use paper towels to absorb excess blood 
and then, again, cover with Ringer’s solution. (Extra pushpins can be used 
to make a more taut rectangle). 
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Figure 8.3 Example of leech pin-out and zoom-in of CNS 
2. Ganglia Preparation 
a. At this point, several ganglia are visible with the naked eye.  Now use a 
microscope and focus on two ganglia of interest; in this experiment, it can 
be any of the ganglia except the four anterior and seven posterior.  
b. Focus on one of the ganglia and begin by pulling and cutting away any 
remaining white tissue that protects the ventral nerve and organs.  Switch 
to other ganglia and repeat. 
c. Switching back and forth between ganglia, use the fine tip surgical 
tweezers and carefully pull away the dark fibers covering the ganglia and 
roots.  Completely expose the ganglia and leave a small amount of dark 
fibers at the end of the thin roots to facilitate later pinning of the ganglia.   
3. Ganglia Extraction 
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a. The ganglia, roots, and ventral nerve are now exposed.  Focus on one 
ganglion and using sharp surgical scissors begin cutting the roots where 
they meet the muscle wall, keeping some of the protective fibers attached 
to the roots.  This step is carried out on both sides of the ganglia until roots 
on either side are free from the muscle wall.  Focus on other ganglia and 
repeat. 
b. Now, cut the ventral nerve of both sides of each ganglion leaving enough 
length to later pin down the ends.  
c. The ganglia are now free-floating.  Carefully remove any instrument so as 
to not accidently pull out the ganglia.  Prepare two small silicon-filled 
petri dishes, one with a bubble of regular Ringer’s solution, the other with 
a bubble of glucose Ringer’s solution. See note. 
Note: The two dishes will be placed on the dark field microscope table that 
need to be in reach of the microscope view.  To center the dishes on the 
microscope table, ganglia need to be as close to the side of their dish as 
possible.   It is necessary to keep in mind which solution will go with which 
head stage. For example, if the regular Ringer’s solution will go under head 
stage one, position the ganglion on the right side of the dish. Consequently, 
the glucose Ringer’s solution will go under head stage two and the ganglion 
should be as close to the left side of the dish as possible. See Figure 8.4. 
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Figure 8.4 Example of ganglion positioning and micro-pin orientations 
d. Using the curved-tip tweezers, carefully transfer the free-floating ganglion 
from the leech to its respective Ringer’s solution bubble in the small petri 
dish. Make sure the ganglia stays in the bubble and does not float to an 
edge and dry out. 
4. Pinning-Out the Ganglia 
a. Starting with either ganglion, first focus the microscope on the ganglion.  
Using either or both tweezers, carefully push the ganglion to the bottom of 
the bubble.  Try to straighten out and separate the roots so that the 
ganglion is flat against the silicon. Orient the ganglion so that the ventral 
side is facing up.   
b. Have micro pins at hand and make sure the micro pin tips are sharp.  Also, 
make sure one end of each micro pin is bent so that the ends run parallel 
with the silicone and do not stick straight up.  
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c. Using one or both tweezers, pin either ventral nerve down to the silicone. 
Pin the other ventral nerve stretched across from the first pin so that the 
nerves are slightly taught.  
d. Pin the remaining roots also slightly taught.  It is best to pin the roots in 
the center of whatever fibrous tissue was purposely left on them.   
e. Orient all bent sides of the micro pins to face away from the center of the 
ganglion and pin down securely.  See note. 
Note: Again, keep in mind which head stage the ganglion will be under and 
from which direction the pipette will be coming from. Continuing the example 
from the first note, regular Ringer’s dish will have a pipette coming from left 
side, so orient the bent sides of pins away from the expected entryway of the 
pipette.  See Figure 8.5. 
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Figure 8.5 Final set-up having considered head stage and pipette entrance direction  
f. Now, fill the petri dish with appropriate Ringer’s solution so that the entire 
silicone bottom is covered and the ganglion is fully submerged.   
g. Repeat steps a-f in section IV with the other ganglion. 
h. Refer to Appendix B for leech carcass disposal protocol.   
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CHAPTER 9:  ELECTROPHYSIOLOGICAL OVERVIEW AND 
EXPERIMENTAL PROTOCOLS 
Electrophysiology is the branch of physiology that studies the electrical activity of 
excitable cells and tissues.  Various techniques can measure the movements of ions 
across surface membranes to provide information on ionic currents and membrane 
potential.  Two common techniques used in electrophysiology include the voltage clamp 
and current clamp techniques.  This section will introduce these two common techniques 
as well as describe, in detail, the electrophysiological procedures used for this thesis.   
9.1 Electrophysiological Recording Techniques 
Most bioelectric events, such as the action potential, will cause independent 
responses in two variables: the transmembrane current flow and the membrane potential.  
To study these responses individually, two techniques were developed in which one 
response is held constant while the other can be investigated.  As indicated by their 
names, the voltage clamp technique holds the voltage constant, and the current clamp 
technique holds the current constant.   
9.1.1 Voltage Clamp 
The voltage clamp technique “clamps,” or holds, the membrane potential at a 
constant value so that membrane currents can be measured independently.  For this 
technique, two intracellular electrodes are necessary, one to measure the membrane 
potential (Ec), the other to pass current into the axon (Em).  The voltage clamp amplifier 
measures the difference between the intracellular membrane potential and the command 
voltage and then feeds current into the cell that is proportional to this difference.  If the 
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difference is zero (Ec = Em), the amplifier will not source or sink any current; if the 
difference is positive or negative, the amplifier will pass current proportional to that 
difference to either depolarize or hyperpolarize the cell until the membrane potential 
equals the command voltage (Ec).  Lastly, a current meter connected to the output line of 
the amplifier is used to observe the current behavior in response to membrane potential.  
[27]  A circuit diagram and conceptual representation of the voltage clamp technique is 
shown below in figures Figure 9.1 and Figure 9.2.   
 
Figure 9.1 Circuit diagram of voltage clamp technique [37] 
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Figure 9.2 Conceptual representation of voltage clamp technique [27] 
9.1.2 Current Clamp 
The current clamp technique “clamps”, or holds, the membrane current at a 
constant value so that changes in membrane potential can be measured independently.  
The essence of this technique is the connection of a micropipette to a unity gain buffer 
amplifier whose input resistance is orders of magnitude larger than that of the 
micropipette resistance. [37]  A unity gain buffer has a gain of one, meaning output 
voltage is equal to input voltage, thus, the output voltage follows the voltage at the end of 
the electrode.  Since an ideal buffer amplifier draws in no current, we can assume the 
current through the pipette is “clamped” at zero.  [37]  An amplifier in the configuration 
shown below that is connected to the input node will source or sink all the current down 
the micropipette and be used to stimulate the cell.  Membrane potential can then be 
measured as it depolarizes or hyperpolarizes in response to particular current values.  A 
circuit diagram for the current clamp technique is shown below in Figure 9.3. 
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Figure 9.3 Circuit diagram of current clamp technique [37] 
9.2 Experimental Procedure 
This procedure was designed to investigate the difference in longevity of action 
potential recruitment in a Retzuis cell in glucose Ringer’s solution versus a Retzius cell in 
regular Ringer’s solution.  The timing started when the ganglia were removed from the 
leech and placed in their respective solution.  Every twenty to thirty minutes, sufficient 
stimulus was injected simultaneously to both Retzius cells to depolarize their membrane 
potentials past threshold to recruit and record action potentials. This process of 
stimulating and holding the membrane current at a particular amplitude for a designated 
amount of time is an example of the current clamp technique described above.  The 
experiment was continued until action potentials could no longer be recruited from the 
chosen Retzius cell.  Below is a table showing a typical experiment timetable: 
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Table 9-1 Typical timeframe from leech dissection to apparent cell death 
Dissection  00:00 
In Ringers 00:15-00:30 
First Stimulation 00:30-00:40 
Second Stimulation 1:00 
Subsequent Stimulations Every 20 minutes until 3:00 
Subsequent Stimulations (post 3hrs) Every 10-15 minutes until not more action 
potentials can be recruited 
 
About two to ten stimulations were introduced, as necessary, at every stimulation 
time to recruit and record action potentials in both Retzius cells.  The exact number of 
stimulations at exact intervals across experiments was not recorded since it was not 
necessary as this experiment was intended to measure the difference in longevity of 
action potential recruitment and not their total survival time. However, the total number 
of stimulations per experiment was recorded to compare to the total survival time and 
check for any correlation.  All possible precautions were taken so that both cells would 
experience, and be affected equally, by the same dissection and stimulation protocols.   
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9.2.1 Equipment 
The following lists the tools used to perform the electrophysiological recordings 
in the leech: 
3M Potassium Chloride Solution 
Axoclamp 900A amplifier 
Axoclamp 900A software 
Clampex 10.2 software 
Clampfit 10.2 software 
Computer 
Dark Field Microscope 
Digidata 1440a DAQ unit 
Extracted leech ganglia 
Faraday cage 
Head stage x2 
Lighting  
Microfil 
Micropipettes 
Micropipette Puller 
Oscilloscope 
Recording electrodes 
Ringer’s Solution (Regular and Glucose) 
Silver Silver-Chloridized wires 
Screwdrivers to adjust head stages 
Small petri dish 
Syringe  
9.2.2 Equipment Setup 
The experimental set-up consists of several hardware and software components. 
Recording of electrical signals occurs at the “recording site” which is composed of two 
extracted ganglia in separate, small petri dishes. The two dishes are placed side by side 
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under a dark field microscope within a faraday cage.   Two recording electrodes are 
placed in the recording site, one for each ganglion, using adjustable head stages.  Two 
reference electrodes, one for each petri dish, are placed in by hand. The Axoclamp 900A 
amplifier is set up so that the recording and reference electrodes are configured as a 
current clamp.  The amplifier magnifies the signal’s amplitude where it is then displayed 
on an oscilloscope and read by the computer and Digidata 1440a DAC unit.  The 
computer, also set up to receive information from the Digidata 1440a DAC unit, can now 
be used to analyze the signal.  The Axoclamp software is used to calibrate the equipment 
and monitor electrode impedance.  The Clampex and Clampfit softwares are used to 
record, stimulate, observe, and analyze membrane potential recordings.  A conceptual 
equipment setup diagram is shown in Figure 9.4. 
 
Figure 9.4 Conceptual representation of equipment set-up 
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9.2.3 Electrodes and Noise Reduction 
In this type of experiment, we were working with very fragile organisms and very 
small electrical signal amplitudes (mV and nA).  As such, it is crucial to use electrodes 
that can penetrate the cell membrane without causing considerable damage as well as 
equipment that can remain sensitive enough to detect such small signals.  To manage 
these criteria, glass capillary microelectrodes, or micropipettes, were used within a 
Faraday cage.   Micropipettes are hollow glass cylinders that are heated and pulled to 
form a sharp tip.  The micropipettes are filled with 3M potassium chloride solution with 
MicroFil TM syringes and are then slid over silver silver-chloridized wires attached to 
the head stages. Each head stage has a paired, standard reference electrode that is placed 
in the same Ringer’s solution bath as the micropipette tip to complete the circuit.  All 
recordings are performed in a Faraday chamber to minimize the amount of unwanted 
electrical interference coming from sources such as the computer, lighting, and electrical 
outlets.  
9.2.4 Micropipette Preparation 
The following describes the steps to arrange two head stages with micropipettes in 
preparation for equipment calibration and cell recording implementation: 
1. Make sure Axoclamp amplifier is turned off before handling electrodes. 
2. Pull two or more pipettes with the micropipette puller. Refer to APPENDIX C for 
detailed instructions. 
3. Place a silver silver-chloridized wire on each head stage. 
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4. Fill micropipette with 3M KCL solution using a microfil attached to a syringe. Make 
sure to remove any air from syringe first and that microfilm reaches maximum depth 
of pipette when filling with solution.  Slowly pull microfil out while injecting 
solution.   
5. Slide the filled micropipettes over the silver silver-chloridized wires and tighten to 
head stage. 
6. Place a petri dish filled with original Ringer’s solution between both head stages and, 
using the adjustments, carefully insert the tip of each micropipette into the Ringer’s 
solution.  You will notice a little dimple in the solution when the pipette tip has 
entered the solution.   
7. Carefully place both ground electrodes in the Ringer’s bath to complete the circuits.  
9.2.5 Calibration Protocol 
The following lists the steps for calibrating the electrodes and preparing 
equipment for cell recording: 
1. Turn on computer, Digidata 1440A DAQ unit, both oscilloscopes, and the Axoclamp 
900A amplifier. 
2. Open the Axoclamp 900A software. 
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Figure 9.5 Axoclamp commander software interface 
3. On the Axoclamp Commander Software Interface, make sure both head stages have 
IC selected.  
4. Using the I-Clamp 1 and I-Clamp 2 tabs, make sure pipette capacitance and bridge 
balance are unclicked on both head stages (I-Clamp 1 is for head stage 1 and I-Clamp 
2 is for head stage 2). 
5. Check the pipette resistance by checking the Rt box next to the voltage display.  The 
resistance must be between 20MΩ and 80 MΩ.  If the resistance is not within that 
range, repeat the micropipette preparation procedure until the resistance is correct.   
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6. In the pipette offset box, click the lock and then zero. This zeros the position of the 
potential. 
7. Starting with head stage 1, on the I-Clamp 1 tab, check the tuning box. Change the 
source on the oscilloscope to CH1 and, using the Trigger knob, move the arrow to fit 
within the pulse train to lock the signal.  
8. Check Pipette Capacitance Neutralization and adjust its value until the rising edge of 
the pulse has a slight overshoot. This step removes any stray capacitance that can 
have a negative impact on the bandwidth of the recording.  An example of stray 
capacitance can be seen in Figure 9.6 a) and b). 
9. Check the Bridge Balance box and adjust its value until the pulse train displays a 
straight line.  The value will be close to that of the resistance value, as this step is 
calibrating out the micropipette resistance (Rp).  Passing current through the 
electrode produces a voltage drop across the electrodes resistance (I Rp).  When 
subtracting that voltage drop from the total voltage (Vp), only membrane potential is 
left (Vm).  See Figure 9.6. This concept can be represented by the equation shown 
below.   
Vp – I Rp = Vm …………………..Equation 4 
10.  Once again, zero the pipette offset. Now, only Pipette Capacitance Neutrality and 
Bridge Balance should be checked. 
11. Repeat steps 7-10, now for head stage 2.  
It is necessary to calibrate the electrodes with every new experiment.  As seen 
in Figure 9.6 b), the capacitance, resistance, and voltage associated with the 
pipette creates a low pass filter.  Calibrating removes the capacitance, opening the 
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circuit and removing the filtering, thus allowing for a wider range of frequencies 
to be observed.  
 
Figure 9.6 Capacitance and resistance calibration 
9.2.6 Cell Recording Implementation 
After the completion of the dissection and calibration protocols, cell recording can 
begin.  The following lists the steps involved in visualizing a Retzius cell, inserting the 
pipette into the Retzius cell, stimulating and recording action potentials for two ganglia in 
different petri dishes: 
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Figure 9.7 Electrophysiological recording 
1. Turn off the Axoclamp amplifier and remove pipettes from petri dish containing the 
Ringer’s solution used for calibration of the pipettes.  
2. Place both petri dishes containing the pinned down ganglia under the dark field 
microscope.  It would be wise to face pipettes towards the back and out of the way 
while placing the petri dishes under the microscope to avoid accidentally hitting the 
pipettes.  Orient the dishes so that the pinned down ganglia are right next to one 
another, both within the center of view of the microscope.    
3. Using the 4X magnification, bring one of the ganglia into focus.  Adjust the center of 
view, microscope lighting and focus using the respective knobs below the head stage 
table to center and clearly visualize the ganglia and the Retzius cells.  
4. Now inspect the ganglia for any appreciable damage or abnormalities.  Repeat the 
dissection protocol if any damage or abnormalities are found.  Check the orientation 
of the micro pins and make any necessary adjustments if they are not properly 
oriented.   
5. Repeat steps 3 and 4 for the other ganglia.  
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6. Once both petri dishes and ganglia are correctly positioned under the microscope, use 
the adjustable head stage to bring the tip of the pipettes into the Ringer’s solution of 
the petri dish closest to it.  Insert the reference electrodes into their corresponding 
dish.   
7. Turn on the Axoclamp amplifier and re-check the electrode impedances on the 
Axoclamp software interface.  Impedance values must be between 20 MΩ and 80 
MΩ.  If either is not in that range, repeat the micropipette preparation and calibration 
protocol for the necessary replacement micropipette(s).  
8. Starting with either ganglion, use the fine adjustments on the head stage to bring the 
pipette as close to the ganglia as possible.  Then use the 4X eye to visualize the tip of 
the pipette.  The tip of the pipette will be just under the surface of the Ringer’s 
solution and focal length adjustment will be necessary to bring it into view.  
9. Continue to use the head stage fine adjustments to bring the tip of the pipette directly 
over the center of the ganglion.  Lower the pipette while simultaneously adjusting the 
focus to always keep the tip of the pipette in focus until the pipette is close, but not 
touching the ganglion. 
10. Now, identify the Retzius cell using the ganglion map shown in Figure 8.2 A.  Keep 
in mind, orientation of the pinned ganglion may not be consistent with the orientation 
seen in the map.   
11. Once the Retzius cell is identified, use the head stage fine adjustments to move the 
pipette to the side of the Retzius cell.  Puncturing of the cell membrane will occur on 
the side of the cell that is closest to the head stage, meaning the pipette should not be 
reaching over the cell, rather it should be just barely approaching it.  
12. Once the pipette tip is on the correct side of the cell, continue using the fine 
adjustments to carefully insert the tip into the cell.   If the pipette looks like it is 
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puncturing the cell but no voltage drop is observed on the oscilloscope, the head 
stage adjustment can be softly tapped to help the tip into the cell.   
13. If the micropipette tip is in the cell, a drop in voltage will be observed on the 
oscilloscope on the order of -30 to -40 mV, assuming the voltage was zeroed prior to 
entering the cell.   Spontaneous depolarizations will also occur without stimulation.   
14. Repeat steps 8 – 13 for the other ganglia.   
15. Once the pipettes are in both Retzius cells, use the Clampex software to stimulate and 
record action potentials.   
9.3 Stimulation and Action Potential Recruitment Parameters 
As mentioned before, both cells (one in each solution) were stimulated 
simultaneously with the same parameters.  Stimulation values ranged from .1 to .3 
nanoAmps (most at .3nA) for a duration of 50 milliseconds.  The range of stimulation 
amplitude occurred when low amplitude was insufficient for action potential stimulation.  
Number of stimulation repeats depended on action potential recruitment for both cells; 
some stimulation times (usually earlier in the experiment) required only a few 
stimulations to record action potentials in both cells, while others (usually later in the 
experiment) required several stimulations to record action potentials in both cells. 
Number of stimulations per experiment was recorded and analyzed to check for any 
correlations to longevity of cell survival.  
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CHAPTER 10:  RESULTS AND CONCLUSIONS 
Several analyses were done on the data collected to check for any impact on 
longevity of Retzius cell survival in regular Ringer’s solution compared to glucose 
Ringer’s solution.  Experiments were performed with the intention that all steps of the 
experiment affected both Retzius cells (one in each solution) identically and 
simultaneously.  Minitab
®
 Statistical Software and Matlab
®
 Mathworks Inc were used to 
perform basic statistical analysis to discover if glucose Ringer’s solution would keep a 
Retzius cell alive longer than regular Ringer’s solution.  This section will show results for 
analyses done on factors that may have impacted cell longevity as well as document any 
conclusions that can be made from said analyses.  Please refer to Appendix D for all 
Minitab
®
 Statistical Software and Matlab
®
 Mathworks Inc raw analysis outputs and 
codes.  
10.1 Action Potential Recordings 
Clampex software was used to stimulate and record action potentials.  Most 
stimulations were done with an amplitude of .3 nA for a duration of 50 ms. Each 
stimulation automatically recorded 500 ms of data.  Figure 10.1 shows examples of what 
recorded Retzius cell action potentials look like at the beginning of an experiment 
(30mins to an hour in) versus what they look like towards the end (3-5 hours in).  When 
no evidence of an action potential was recorded after repeated stimulations, the cell 
would be assumed dead and total cell survival time recorded and used for data analysis.   
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A. B.                                                                       
Figure 10.1 Clampex software action potential recordings A. Early in experiment B. Later in 
Experiment 
10.2 Survival Time of Retzius Cells in Ringer's Solutions 
The goal of this thesis was to determine whether or not a glucose-enriched 
Ringer’s solution would extend the longevity of a leech Retzius cell when compared to a 
regular Ringer’s solution which does not contain glucose.  The hypothesis was that a 
glucose-enriched solution would in fact allow for a longer experimental time frame.  
Matlab
®
 Mathworks Inc was used to plot the mean survival times of the Retzius cell in 
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both solutions.  See Figure 10.2 below.  Basic statistics performed using Minitab
®
 
Statistical Software provided the values used to make this plot.  The mean survival time 
of the Retzius cell in regular Ringer’s solution was 210.7 minutes with a standard 
deviation of 68.  The mean survival time of the Retzius cell in glucose-enriched Ringer’s 
solution was 256.0 minutes with a standard deviation of 47.   
A paired student t-test was performed using Minitab
®
 Statistical Software to 
determine whether or not the Retzius cell survival time was significantly greater than the 
survival time in regular Ringer’s solution.  For this test, the difference of means was set 
to thirty minutes.  This value was chosen as the minimal amount of time that would make 
the addition of glucose to Ringer’s solution worthwhile by allowing significant increased 
longevity to make alterations to an experimental paradigm.  The paired t-test was run 
with a 95% confidence interval and results gave a T-value of 0.84 and a p-value of 0.207.  
These values indicate that glucose Ringer’s solution did not significantly extend the 
longevity of the Retzius cell by thirty minutes compared to regular Ringer’s solution.   
A second paired t-test was performed to check for any statistical difference 
between the survival times of the Retzius cell in glucose Ringer’s solution versus regular 
Ringer’s solution.  The means were compared with a 95% confidence interval and gave a 
T-value of 2.49 and a p-value of 0.026.  These values demonstrate that there is a 
statistical difference between the survival rates of the Retzius cell in glucose Ringer’s 
solution versus regular Ringer’s solution with a 95% confidence that the Retzius cell in 
glucose Ringer’s solution will survive between 6.3 and 84.3 minutes longer than the 
Retzius cell in regular Ringer’s solution.   
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Figure 10.2 Bar graph showing the mean survival times of Retzius cell submerged in regular 
Ringer’s solution versus glucose Ringer’s solution.  * indicates P-value < .05 with mean difference 
equal to 0. 
10.3 Stimulation Correlation 
In order to perform further analysis, it was necessary to clarify the effect stimulations 
may have had on the survival time of the cells.  Each experiment had a different number 
of stimulations depending on two things: action potential recruitment (action potentials 
recorded in both cells) and cell survival time (the longer the cells survived, the more 
stimulations they would receive).  If stimulations impacted cell longevity, it would not be 
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possible to compare total survival time across experiments because the number of 
stimulation would introduce an additional variable.  However, if number of stimulations 
shows no correlation to cell longevity, we could use total survival time of the cells for 
further analysis.   
Minitab
®
 Statistical Software was used to create the scatterplot shown in Figure 10.3 
to show possible correlations between cell longevity and number of stimulations.  Each 
point represents the survival time of individual experiments and is plotted as a function of 
the number of stimulations for that particular experiment.  Black markings represent 
experiments in regular Ringer’s solution and red markings represent experiments in 
glucose Ringer’s solution.  Linear regression analysis completed on this data shows that 
cell longevity in neither regular Ringer’s solution nor glucose Ringer’s solution has any 
correlation to number of stimulations with an R squared value of 0.6%.   
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Figure 10.3 Scatter plot comparing regular Ringer’s solution and glucose Ringer’s solution to 
number of stimulations 
10.4 Head-Stage Impact 
The last variable that was tested to check for any effect on cell longevity is the 
head-stages used during the experiment.  Fifteen experiments were performed; eight with 
regular Ringer’s on head-stage one and seven with glucose Ringer’s on head-stage one.  
Minitab
®
 Statistical Software was used to perform two two-sample Student’s t tests to 
verify any correlation between cell longevity and either head-stage one or head-stage 
two.  Analysis showed that neither head-stage impacted cell longevity with a p value of 
0.33 when comparing head-stages to cell survival in regular Ringer’s solution and a p 
value of 0.517 when comparing head-stages to cell survival in glucose Ringer’s solution. 
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10.5 Conclusions 
Analysis of the data disproved the hypothesis that glucose Ringer’s solution will 
keep the Retzius cell alive at least 30 minutes longer than regular Ringer’s solution does. 
There is, however, a significant difference in the overall average longevity of the Retzius 
cell in glucose Ringer’s solution versus regular Ringer’s solution when the difference of 
means is set to zero.    Additionally, the graph comparing stimulation and survival time 
shows the glucose data points at higher survival rates.  Although the graph analysis 
demonstrates no significant correlation between stimulation number and survival, glucose 
does seem to be able to help the cells in some measurable way.  Lastly, the head stages 
were the tested for impact on cell longevity and analysis has shown that neither head 
stage impacted cell longevity in either solution.    
73 
CHAPTER 11:  DISCUSSION 
This thesis was attempting to extend the longevity of cells being studied in vitro 
for electrophysiological purposes.  It was thought that due to the minimal glucose storage 
of nerve cells, glucose deficiency may be the cause of cell death.  Glucose was added to 
regular Ringer’s solution to supply the cell with adequate amounts of fuel to produce 
ATP, and perhaps, cause it to live longer than it would in regular Ringer’s solution alone.  
Results concluded that the addition of glucose to Ringer’s solution did not extend the life 
of cells significantly (at least 30 minutes) to justify adding glucose to regular Ringer’s 
solution.  It would be interesting to understand what, if not lack of fuel, is causing the 
cells to die after 3-5 hours into the experiment. 
When considering what a nerve cell needs to survive, aside from its osmotic 
extracellular environment, glucose and oxygen are critical for cells to sustain their 
membrane potential.  With this in mind, it can be considered that glucose is not able to 
get into the cell from the extra-ganglionic solution.  In addition, perhaps oxygen supplied 
from Ringer’s solution’s contact with the air is not sufficient for the cell to produce 
adequate amounts of ATP.  Ideas for future studies include investigation of whether or 
not the cells are getting access to the glucose provided in the Ringer’s solution as well as 
aerating the solution in a manner similar to aeration of fish tanks.   A “flowing system” is 
commonly used in electrophysiogical experiments and can be used to supply a fresh, 
glucose-enriched, aerated solution to the ganglia throughout the entire experiment.   
Additionally, there are a few variables difficult to control that occur with 
experiments such as the ones in this thesis that could potentially impact cell longevity.  
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The first is the dissection protocol.  As much as one tries to perform dissections equally 
across experiments, there can be differences in time or effort required to remove ganglia.  
Remember, the protocol calls for using a surgical tweezers to remove all protective 
covering from the ganglia.  This includes applying pressure and a general disturbing of 
the ganglia.  It is necessary to be very careful during this procedure and also when 
inspecting for any appreciable damage that may have occurred during dissection that 
would require a repeat of the procedure.   
 Lastly, but perhaps most importantly, is the need to puncture the cell 
membrane for cell stimulation and action potential recordings.  The experimental 
procedure followed in this thesis attempted one “puncturing” of the cell membrane for 
stimulating and recording purposes, but additional re-entering of the cell was very often 
necessary as the pipette would get “pushed” out of the cell and need to be reinserted.  
Based on observation only, it seemed that the experiments tended to last longer when 
very few pipette adjustments were necessary throughout the experiment, versus other 
experiments that required many re-insertions of the pipette.   This variability is difficult 
to control, but I would hypothesize that the puncturing of the cell membrane is a 
contributing factor affecting cell longevity.   
 In summary, although the addition of glucose to Ringer’s solution did not 
extend the life of the Retzius cell by at least thirty minutes when compared to regular 
Ringer’s solution, some measurable difference was statistically shown.  With this 
information, the addition of glucose to Ringer’s solution may in fact be beneficial to cell 
survival.  All possible precautions were taken to eliminate variables that would affect 
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longevity and those possible to test were found to have no correlation and therefore no 
appreciable effect on cell survival time.    
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APPENDICES: 
APPENDIX A 
Ringer’s solutions calculations mentioned in Chapter 7: 
Below are the calculations used to figure out the amount of 3M NaCl needed to make 1L 
of 115 mM NaCl. All subsequent calculations will follow the same two steps.  
Step 1, calculate the number of moles of NaCl needed for a 115 mM solution: 
M =  
m
V
 ……………………….………….Equation 4 
. 115
moles
liters
=  
m
1L
 
m = .115 moles 
Step 2, calculate volume of 3M NaCl that gives the number of moles of NaCl from step 
1: 
Rearrange Equation 3 to V =  
m
M
, and solve for volume. 
V liters =  
. 115moles
3
moles
liter
 
V = .038 L  38mL 
We need 38 mL of 3 molar NaCl in 1 liter of distilled water to make a 115 mM solution. 
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Below are the calculations used to figure out the amount of 1M CaCl2needed to make 1L 
of 1.8 mM CaCl2.  
. 0018
moles
liters
=  
m
1L
 
m = .0018 moles 
V liters =  
. 0018moles
1
moles
liter
 
V = .0018 L  1.8mL 
We need 1.8 mL of 1 molar CaCl2 in 1 liter of distilled water to make a 1.8 mM solution. 
Below are the calculations used to figure out the amount of 1M KCl needed to make 1L 
of 4 mM KCl. 
. 004
moles
liters
=  
m
1L
 
m = .0018 moles 
V liters =  
. 004moles
1
moles
liter
 
V = .004 L  4mL 
We need 4 mL of 1 molar KCl in 1 liter of distilled water to make a 4 mM solution. 
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Below are the calculations used to figure out the amount of 0.2 M Tris maleate needed to 
make 1L of 10 mM KCl. 
. 01
moles
liters
=  
m
1L
 
m = .01 moles 
V liters =  
. 01moles
. 2
moles
liter
 
V = .05 L  50mL 
We need 50 mL of 0.2 molar Tris maleate in 1 liter of distilled water to make a 10 mM 
solution. 
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APPENDIX B 
Proper disposal of leech carcass mentioned in Chapter 8: 
1) When leech dissection is complete, leech carcass can be placed in the refrigerator until 
experimenter is ready to dispose of it.  
2) When ready to dispose of leech, use surgical scalpel to cut both the head and tail of the leech 
where marked in blue in Figure 11.1.   
 
Figure 11.1 Image of leech carcass with blue line indicating cutting points for disposal of 
leech 
3) Remove pins one by one and use paper towel to wipe needles and collect leech parts.   
4) Place paper towel containing leech remains in an appropriate freezer with receptacle for bio-
hazards. 
5) Rinse Petrie dish well with water and pat/press clean using paper towels. 
6) Make sure to wash your hands after handling leech dissection instruments. 
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APPENDIX C 
Micropipette pulling instructions mentioned in Chapter 9: 
 
Figure 11.2 Pipette Puller 
1. Secure a glass pipette into slot on the right side of the heating components by 
turning knob until tight.  Make sure to push pipette through far enough left to be 
able to secure other end of pipette with the left knob.  
2. Press tabs on both sides to slide knobs together and secure the extended end of 
the pipette with the left knob.  
3. Adjust location of pipette within knobs so that after being pulled about, the 
pipette remaining on the left side is about 1.5 inches long.  
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Figure 11.3 Image of glass pipette pushed towards the left and secured by both knobs 
4. Power on pipette puller and load program number 33.  Settings are already saved 
into the program (P = 500, Heat = 500, Pull = 95, Vel. = 80, Del. = 120).  If it is 
found necessary to adjust resistance values provided by these settings, pull and 
delay and be fine-tuned to increase or decrease resistance. To lower the 
resistance, decrease pull or increase delay; to increase the resistance, increase 
pull or decrease delay.   
5. Once pipette is properly placed and secured, close lid and press pull. The center 
heating components will turn red and a loud snap will be heard as the glass is 
pulled apart. 
6. Once pulling is complete, wait until cooling is done (you will feel the light 
vibration on the machine stop when it is done; about 10 seconds). 
7. When cooling is done, open lid and carefully remove pulled pipette without 
touching the tip! Place in secure pipette holder until ready to use. 
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Figure 11.4 A. Pulled pipette B. Pipette tips stored 
8. Repeat steps 1-7 with remaining glass from right side. Sharp side must be facing 
inwards when pulling the second pipette tip. 
9. When done pulling, remove any remaining glass and place in appropriate sharps 
container. Then close the lid and power down the machine. 
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APPENDIX D 
Matlab and Minitab Data Analysis mentioned in Chapter 10: 
Matlab: 
 
glucose_avg = 256 
reg_avg = 210.7 
glucose_SD = 47 
reg_SD = 68 
Labels = {'Regular Ringers Solution', 'Glucose Ringers Solution'} 
figure 
bar([reg_avg,glucose_avg],0.5,'displayname',['Ringers','glucose'],'facecolor',[0.8, 0.8, 
0.8]) 
hold on 
set(gca, 'XTick', 1:2, 'XTickLabel', Labels); 
errorbar(1:2,[reg_avg,glucose_avg],[reg_SD,glucose_SD],'.','Color','k') 
 
Minitab: 
 
Descriptive Statistics: total reg ringers, total glucose ringers  
Variable                N  N*   Mean  SE Mean  StDev  Minimum  Median  Maximum 
total reg ringers      15   0  210.7     17.6   68.0    113.0   230.0    300.0 
total glucose ringers  15   0  256.0     12.1   47.0    165.0   275.0    300.0 
 
Paired T-Test and CI: total glucose ringers, total reg ringers  
Paired T for total glucose ringers - total reg ringers 
                        N   Mean  StDev  SE Mean 
total glucose ringers  15  256.0   47.0     12.1 
total reg ringers      15  210.7   68.0     17.6 
Difference             15   45.3   70.4     18.2 
95% CI for mean difference: (6.3, 84.3) 
T-Test of mean difference = 0 (vs not = 0): T-Value = 2.49  P-Value = 0.026 
  
Paired T-Test and CI: total glucose ringers, total reg ringers  
Paired T for total glucose ringers - total reg ringers 
                        N   Mean  StDev  SE Mean 
total glucose ringers  15  256.0   47.0     12.1 
total reg ringers      15  210.7   68.0     17.6 
Difference             15   45.3   70.4     18.2 
95% lower bound for mean difference: 13.3 
T-Test of mean difference = 30 (vs > 30): T-Value = 0.84  P-Value = 0.207 
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Regression Analysis: total reg ringers versus numb of stims  
The regression equation is 
total reg ringers = 221 - 0.127 numb of stims 
Predictor         Coef  SE Coef      T      P 
Constant        220.51    40.09   5.50  0.000 
numb of stims  -0.1270   0.4609  -0.28  0.787 
S = 70.3940   R-Sq = 0.6%   R-Sq(adj) = 0.0% 
Analysis of Variance 
Source          DF     SS    MS     F      P 
Regression       1    376   376  0.08  0.787 
Residual Error  13  64419  4955 
Total           14  64795 
Unusual Observations 
     numb of  total reg 
Obs    stims    ringers    Fit  SE Fit  Residual  St Resid 
 15      168      182.0  199.2    45.5     -17.2     -0.32 X 
X denotes an observation whose X value gives it large leverage. 
 
Regression Analysis: total glucose ringers versus numb of stims  
The regression equation is 
total glucose ringers = 225 + 0.402 numb of stims 
Predictor        Coef  SE Coef     T      P 
Constant       224.83    26.04  8.64  0.000 
numb of stims  0.4020   0.2993  1.34  0.202 
S = 45.7105   R-Sq = 12.2%   R-Sq(adj) = 5.4% 
Analysis of Variance 
Source          DF     SS    MS     F      P 
Regression       1   3769  3769  1.80  0.202 
Residual Error  13  27163  2089 
Total           14  30932 
Unusual Observations 
                total 
     numb of  glucose 
Obs    stims  ringers    Fit  SE Fit  Residual  St Resid 
  1       83    165.0  258.2    11.9     -93.2     -2.11R 
 15      168    296.0  292.4    29.5       3.6      0.10 X 
R denotes an observation with a large standardized residual. 
X denotes an observation whose X value gives it large leverage. 
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Two-Sample T-Test and CI: total reg ringers, HS  
Two-sample T for total reg ringers 
                       SE 
HS  N   Mean  StDev  Mean 
0   8  227.4   66.9    24 
1   7  191.6   69.1    26 
Difference = mu (0) - mu (1) 
Estimate for difference:  35.8 
95% CI for difference:  (-41.0, 112.6) 
T-Test of difference = 0 (vs not =): T-Value = 1.02  P-Value = 0.330  DF = 12 
 
Two-Sample T-Test and CI: total glucose ringers, HS  
Two-sample T for total glucose ringers 
HS  N   Mean  StDev  SE Mean 
0   8  248.4   52.0    18 
1   7  264.7   42.9    16 
Difference = mu (0) - mu (1) 
Estimate for difference:  -16.3 
95% CI for difference:  (-69.7, 37.0) 
T-Test of difference = 0 (vs not =): T-Value = -0.67  P-Value = 0.517  DF = 12 
